Mahdi M Najafabadi

Dr. Mahdi M Najafabadi

York University
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2020 in Healthcare
Verified
Journal Article
Open access
PDF file
Ali AsgaryAli Asgary
Ali Asgary
Mahdi M NajafabadiMahdi M Najafabadi
Mahdi M Najafabadi
RKRichard Karsseboom
Richard Karsseboom
JWJianhong Wu
Jianhong Wu
Several research and development teams around the world are working towards COVID-19 vaccines. As vaccines are expected to be developed and produced, preparedness and planning for mass vaccination and immunization will become an important aspect of the pandemic management. Mass vaccination has been used by public health agencies in the past and is being proposed as a viable option for COVID-19 immunization. To be able to rapidly and safely immunize a large number of people against SARS-CoV-2, different mass vaccination options are available. Drive-through facilities have been successfully used in the past for immunization against other diseases and for testing during COVID-19. In this paper we introduce a drive-through vaccination simulation tool that can be used to enhance the planning, design, operation, and feasibility and effectiveness assessment of such facilities. The simulation tool is a hybrid model that integrates discrete event and agent-based modeling techniques. The simulation outputs visually and numerically show the average processing and waiting times and the number of cars and people that can be served (throughput values) under different numbers of staff, service lanes, screening, registration, immunization, and recovery times.

23 September 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
Amir KaramiAmir Karami
Amir Karami
MZMichael Zhu
Michael Zhu
BGBailey Goldschmidt
Bailey Goldschmidt
HBHannah R. Boyajieff
Hannah R. Boyajieff
Mahdi M NajafabadiMahdi M Najafabadi
Mahdi M Najafabadi
The understanding of the public response to COVID-19 vaccines is the key success factor to control the COVID-19 pandemic. To understand the public response, there is a need to explore public opinion. Traditional surveys are expensive and time-consuming, address limited health topics, and obtain small-scale data. Twitter can provide a great opportunity to understand public opinion regarding COVID-19 vaccines. The current study proposes an approach using computational and human coding methods to collect and analyze a large number of tweets to provide a wider perspective on the COVID-19 vaccine. This study identifies the sentiment of tweets using a machine learning rule-based approach, discovers major topics, explores temporal trend and compares topics of negative and non-negative tweets using statistical tests, and discloses top topics of tweets having negative and non-negative sentiment. Our findings show that the negative sentiment regarding the COVID-19 vaccine had a decreasing trend between November 2020 and February 2021. We found Twitter users have discussed a wide range of topics from vaccination sites to the 2020 U.S. election between November 2020 and February 2021. The findings show that there was a significant difference between tweets having negative and non-negative sentiment regarding the weight of most topics. Our results also indicate that the negative and non-negative tweets had different topic priorities and focuses. This research illustrates that Twitter data can be used to explore public opinion regarding the COVID-19 vaccine.

Ali AsgaryAli Asgary
Ali Asgary
SVSvetozar Valtchev
Svetozar Valtchev
MCMichael Chen
Michael Chen
Mahdi M NajafabadiMahdi M Najafabadi
Mahdi M Najafabadi
JWJianhong Wu
Jianhong Wu
Planning for mass vaccination against SARS-Cov-2 is ongoing in many countries considering that vaccine will be available for the general public in the near future. Rapid mass vaccination while a pandemic is ongoing requires the use of traditional and new temporary vaccination clinics. Use of drive-through has been suggested as one of the possible effective temporary mass vaccinations among other methods. In this study, we present a machine learning model that has been developed based on a big dataset derived from 125K runs of a drive-through mass vaccination simulation tool. The results show that the model is able to reasonably well predict the key outputs of the simulation tool. Therefore, the model has been turned to an online application that can help mass vaccination planners to assess the outcomes of different types of drive-through mass vaccination facilities much faster.

12 January 2021 in BMC Public Health
Verified
Journal Article
Open access
PDF file
Ali AsgaryAli Asgary
Ali Asgary
MCMonica Cojocaru
Monica Cojocaru
Mahdi M NajafabadiMahdi M Najafabadi
Mahdi M Najafabadi
JWJianhong Wu
Jianhong Wu
Background: School testing for SARS-CoV-2 infection has become an important policy and planning issue as schools were reopened after the summer season and as the COVID-19 pandemic continues. Decisions to test or not to test and, if testing, how many tests, how often and for how long, are complex decisions that need to be taken under uncertainty and conflicting pressures from various stakeholders. Method: We have developed an agent-based model and simulation tool that can be used to analyze the outcomes and effectiveness of different testing strategies and scenarios in schools with various number of classrooms and class sizes. We have applied a modified version of a standard SEIR disease transmission model that includes symptomatic and asymptomatic infectious populations, and that incorporates feasible public health measures. We also incorporated a pre-symptomatic phase for symptomatic cases. Every day, a random number of students in each class are tested. If they tested positive, they are placed in self-isolation at home when the test results are provided. Last but not least, we have included options to allow for full testing or complete self-isolation of a classroom with a positive case. Results: We present sample simulation results for parameter values based on schools and disease related information, in the Province of Ontario, Canada. The findings show that testing can be an effective method in controlling the SARS-CoV-2 infection in schools if taken frequently, with expedited test results and self-isolation of infected students at home. Conclusions: Our findings show that while testing cannot eliminate the risk and has its own challenges, it can significantly control outbreaks when combined with other measures, such as masks and other protective measures.

18 August 2022 in IEEE Transactions on Engineering Management
Verified
Journal Article
Closed access
Jalal PossikJalal Possik
Jalal Possik
Ali AsgaryAli Asgary
Ali Asgary
ASAdriano O. Solis
Adriano O. Solis
Gregory ZacharewiczGregory Zacharewicz
Gregory Zacharewicz
MSMohammad Ali Shafiee
Mohammad Ali Shafiee
JWJianhong Wu
Jianhong Wu
Hospitals and other healthcare settings use various simulation methods to improve their operations, management, and training. The COVID-19 pandemic, with the resulting necessity for rapid and remote assessment, has highlighted the critical role of modeling and simulation in healthcare, particularly distributed simulation (DS). DS enables integration of heterogeneous simulations to further increase the usability and effectiveness of individual simulations. This article presents a DS system that integrates two different simulations developed for a hospital intensive care unit (ICU) ward dedicated to COVID-19 patients. AnyLogic has been used to develop a simulation model of the ICU ward using agent-based and discrete event modeling methods. This simulation depicts and measures physical contacts between healthcare providers and patients. The Unity platform has been utilized to develop a virtual reality simulation of the ICU environment and operations. The high-level architecture, an IEEE standard for DS, has been used to build a cloud-based DS system by integrating and synchronizing the two simulation platforms. While enhancing the capabilities of both simulations, the DS system can be used for training purposes and assessment of different managerial and operational decisions to minimize contacts and disease transmission in the ICU ward by enabling data exchange between the two simulations.

18 June 2019
Verified
Conference Paper
Open access
THTeresa Harrison
Teresa Harrison
LLLuis F. Luna-Reyes
Luis F. Luna-Reyes
TPTheresa Pardo
Theresa Pardo
NPNic De Paula
Nic De Paula
Mahdi M NajafabadiMahdi M Najafabadi
Mahdi M Najafabadi
JPJillian Palmer
Jillian Palmer